Cohen Jacob D. bought MGRX

July 21, 2025 · Form 4 insider transaction

Cohen Jacob D. bought 50,000 shares of Mangoceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 242 days after the transaction.

Direction
Acquired (buy-side)
Shares
50,000
Price
N/A
Total value
N/A
Role—
SecurityWarrant to Purchase Common Stock
Transaction codeA: Grant or award
Transaction dateJuly 21, 2025
Filing dateMarch 20, 2026
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company.; Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein.

View the original Form 4 on SEC EDGAR